# HTX-011 Administration Study in Planned Caesarean Section Procedure

> **NCT03955211** · PHASE2 · COMPLETED · sponsor: **Heron Therapeutics** · enrollment: 25 (actual)

## Conditions studied

- Analgesia

## Interventions

- **DRUG:** HTX-011
- **DRUG:** HTX-011
- **DEVICE:** Luer Lock Applicator
- **DRUG:** Ibuprofen
- **DRUG:** Acetaminophen

## Key facts

- **NCT ID:** NCT03955211
- **Lead sponsor:** Heron Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-24
- **Primary completion:** 2021-12-03
- **Final completion:** 2021-12-27
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03955211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03955211, "HTX-011 Administration Study in Planned Caesarean Section Procedure". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03955211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*